HGENQ — Humanigen Income Statement
0.000.00%
- $0.00m
- -$3.10m
- $2.51m
Annual income statement for Humanigen, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 0.312 | 3.6 | 2.51 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 11.4 | 8.94 | 88.5 | 236 | 70.8 |
Operating Profit | -11.4 | -8.94 | -88.2 | -233 | -68.3 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -12 | -10.3 | -89.5 | -237 | -70.7 |
Provision for Income Taxes | |||||
Net Income After Taxes | -12 | -10.3 | -89.5 | -237 | -70.7 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -12 | -10.3 | -89.5 | -237 | -70.7 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -12 | -10.3 | -89.5 | -237 | -70.7 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.627 | -0.46 | -2.42 | -4.04 | -0.793 |